Partnership Opportunities

HER2 Targeted Therapy aims to match solution providers and vendors with decision-makers dealing with distinct technical and strategic challenges in HER2 drug development to support their pipelines at all stages of therapeutic development, no matter what disease or modality. This forum will allow you to form those vital connections as well as, providing you with an opportunity to showcase the technologies that are changing the game, including:

Preclinical Modeling:

This year interest in Ex vivo technology and strategies has grownsignificantly and is a key discussion point for the field alongside traditional PDX, Syngeneic, and Humanized models

3D Organoid/In Silico Modeling:

The capabilities of non-animal approaches to preclinical analysis and the cost of these processes relative to what they offer from a regulatory perspective

Toxicology Screening:

Identifying toxicity risks with various modalities and cancer types to more confidently translate to the clinic

Clinical Development:

Position yourself as the leading Clinical Research organization in the space to accelerate and support clinical development

Target Discovery:

Showcase your capabilities to boost the early development of immune-oncology and ADC therapies


Display your regulatory expertiseto support developers in their efforts

Why Partner?

PArtnership icon 1

Set yourself apart

from other service providers through exclusive branding opportunities designed to assert you as the go-to solution for oncology therapeutics developers.

PArtnership icon 2

Showcase your capabilities by positioning

your service to the oncology developers working with antibodies and cell therapies alike. Address their key commercial and clinical challenges at the preclinical, clinical and commercial  development stages.

PArtnership icon 3

Strategize your next steps through

learning where the market trends are heading in the post Enhertu age through a jam-packed packed agenda covering all HER2 targeting technical and strategic roadblocks.

This is your opportunity to become part of the HER2 global expansion and showcase your expertise in solution services.

If you provide services in tumor models, antibody manufacturing, clinical trials, diagnostics, biomarkers, or product development technology, now’s the time to get in front of the key decision-makers of the field.

Whether you need to communicate exciting progress, are looking to generate leads, or would like to understand what next-generation investments the market wants, you can rely on our ability to advise and deliver the right solution for you.

Get in touch today to learn more about bespoke partnership opportunities.